US: AFFY - Affymax Inc.

Yield per half year: -61.9%

Share chart Affymax Inc.


About

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.


IPO date 2006-12-15
ISIN US00826A1097
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.affymax.com
Change price per day: 0% (0.0008)
Change price per week: 0% (0.0008)
Change price per month: 0% (0.0008)
Change price per 3 month: +14.29% (0.0007)
Change price per half year: -61.9% (0.0021)
Change price per year: +33.33% (0.0006)
Change price per 3 year: -99.63% (0.219)
Change price per 5 year: -94.29% (0.014)
Change price per 10 year: 0% (0.0008)
Change price per year to date: 0% (0.0008)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.5 5
Total: 2.35

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -98.81 0
Yield Ebitda, % -50.89 0
Yield EPS, % -131 0
Total: 0

Head Job title Payment Year of birth
Mr. Mark G. Thompson CFO & Secretary 1962 (63 years)
Mr. Jonathan M. Couchman CEO, President & Director 1970 (55 years)
Dr. Tracy J. Dunn Ph.D., J.D. Vice President of Intellectual Property & Legal Affairs 1963 (62 years)

Address: United States, New York, 630 Fifth Avenue - open in Google maps, open in Yandex maps
Website: https://www.affymax.com